Home-Based System Relieves Cirrhosis Refractory Ascites
|
By HospiMedica International staff writers Posted on 11 Jan 2022 |
|
Image: An ascites patient with abdominal paracentesis scars (Photo courtesy of iStock)
A novel tunneled peritoneal catheter (PeCa) drainage system provided significant relief for patients with refractory ascites, according to a new study.
The PeCa implant, developed at Hannover Medical School (Germany), is composed of internal shut that lies in the peritoneal cavity, a tunneled section that passes through subcutaneous tissue, and an external port to which drainage bags are connected. To test system efficacy, outcomes in 152 patients with refractory ascites, who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS) and received a PeCa implant, were compared to 71 patients who received standard care, which included repeated large volume paracentesis and albumin.
The results revealed that factors associated with 90-day survival were PeCa implantation, and each point of Model for End-Stage Liver Disease (MELD) score. Hospitalizations were more common in the PeCa group, for reasons that included spontaneous bacterial peritonitis (SBP), hyponatremia, and infections other than SBP. There was no significant difference in mortality between the two groups, but there were trends in the PeCa group towards higher frequency of acute kidney injury (AKI). The study was presented at the American Association for the Study of Liver Diseases annual conference, held online during November 2021.
“Patients with refractory ascites have a very high risk for rehospitalization, AKI, and death. Our data indicate that PeCa could be a valuable new treatment option for patients with refractory ascites and contraindication for TIPS,” said study co-author and presenter Tammo Lambert Tergast, MD. “I think if we can optimize the treatment after discharge, we can also minimize the rehospitalization in these patients. However, the risk for hyponatremia and AKI has to be considered and further explored.”
Refractory ascites occurs when patients no longer respond to medical therapy, a condition that affects over 100,000 patients in Europe and the United States every year, a number that is growing at approximately 10% a year. The primary treatment for ascites is paracentesis, a procedure in which a large bore needle is inserted into the patient's abdomen to remove between 5‐10 liters of ascites that has accumulated over a period of a week or two.
Related Links:
Hannover Medical School
The PeCa implant, developed at Hannover Medical School (Germany), is composed of internal shut that lies in the peritoneal cavity, a tunneled section that passes through subcutaneous tissue, and an external port to which drainage bags are connected. To test system efficacy, outcomes in 152 patients with refractory ascites, who were not candidates for transjugular intrahepatic portosystemic shunt (TIPS) and received a PeCa implant, were compared to 71 patients who received standard care, which included repeated large volume paracentesis and albumin.
The results revealed that factors associated with 90-day survival were PeCa implantation, and each point of Model for End-Stage Liver Disease (MELD) score. Hospitalizations were more common in the PeCa group, for reasons that included spontaneous bacterial peritonitis (SBP), hyponatremia, and infections other than SBP. There was no significant difference in mortality between the two groups, but there were trends in the PeCa group towards higher frequency of acute kidney injury (AKI). The study was presented at the American Association for the Study of Liver Diseases annual conference, held online during November 2021.
“Patients with refractory ascites have a very high risk for rehospitalization, AKI, and death. Our data indicate that PeCa could be a valuable new treatment option for patients with refractory ascites and contraindication for TIPS,” said study co-author and presenter Tammo Lambert Tergast, MD. “I think if we can optimize the treatment after discharge, we can also minimize the rehospitalization in these patients. However, the risk for hyponatremia and AKI has to be considered and further explored.”
Refractory ascites occurs when patients no longer respond to medical therapy, a condition that affects over 100,000 patients in Europe and the United States every year, a number that is growing at approximately 10% a year. The primary treatment for ascites is paracentesis, a procedure in which a large bore needle is inserted into the patient's abdomen to remove between 5‐10 liters of ascites that has accumulated over a period of a week or two.
Related Links:
Hannover Medical School
Gold Member
12-Channel ECG
CM1200B
Medical-Grade Display
HL2316SHTB
Patient Preoperative Skin Preparation
BD ChloraPrep
Latest Patient Care News
- Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences
- Expert Review Outlines Diagnosis and Treatment of Recurrent Catheter Infections
- Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging
- AI Platform Personalizes Support Between Visits for Cancer Survivors
- At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
- EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
- Virtual Reality Helps Claustrophobic Patients Complete Cardiac PET/CT Scans
- Weighted Blankets Reduce Anxiety in Hospitalized Adults
- Multicenter Study Quantifies Delays in Care for Emergency Department Boarders
- Real-Time Radiation Monitor Supports Safer Fluoroscopy-Guided Procedures
- FDA-Cleared Finger Cuff Device Enables Home Blood Pressure Monitoring
- AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Channels
Artificial Intelligence
view channel
AI Tool Improves Hospital Discharge Summaries to Support Follow-Up Care
Discharge summaries guide care after hospitalization but can be difficult to prepare after long or complex stays. Clinicians must condense treatment, medications, follow-up, and unresolved issues into... Read more
AI Tool Predicts Hypertensive Crisis Up to 72 Hours Ahead
A hypertensive crisis is a rapid and severe rise in blood pressure above 180/120 mm Hg accompanied by acute end-organ damage. It can lead to stroke, heart attack, kidney injury, aortic dissection, or pulmonary... Read more
Critical Care
view channel
Circuit-Free Smart Patch Uses Smartphone Camera to Monitor Pulse and Vessel Stiffness
Routine cardiovascular monitoring often relies on electronic sensors, cables, or specialized equipment, which can limit its use beyond hospitals, ambulances, general practice clinics, and emergency rooms.... Read more
Chest Digital Twin Guides Light Therapy Dosing for Pneumonia
Pneumonia is a lung infection that can impair gas exchange and progress to severe respiratory compromise. Light-based therapies may help treat infection or inflammation, but externally applied light must... Read more
Surgical Techniques
view channel
Dual-Technique Approach Improves Stent Expansion in Calcified Coronary Lesions
Calcified coronary nodules are hard, irregular calcium deposits that protrude into coronary arteries and can complicate percutaneous coronary intervention by preventing full stent expansion.... Read more
FDA Approves First Transcatheter Device for Paravalvular Leak Closure
Paravalvular leak is a backflow of blood around a surgical heart valve that can follow valve replacement, causing heart failure symptoms or hemolysis. These leaks occur in 7%–17% of mitral valve replacements... Read more
Medical Imaging
view channel
Imaging Biomarker Links Breast Tumor Heterogeneity to Targeted Therapy Response
Breast cancer patients can respond differently to targeted therapy, even when their tumors appear similar on conventional imaging. This variability can expose some patients to treatments that provide limited... Read more
AI-Guided Echocardiography Enables Mobile Cardiac Imaging in Rural Communities
Echocardiography uses ultrasound to provide real-time images of cardiac structure and function, but access can be limited in rural communities where testing often depends on expert sonographers, imaging... Read more
Privacy-Preserving AI Tool Synthesizes CT for Radiation Therapy Planning
Radiation therapy planning depends on accurate medical imaging to calculate dose, visualize organs, and position patients during treatment. Hospitals need large imaging datasets to train robust artificial... Read more
Tissue Around Breast Microcalcifications Emerges as a Key Source of Diagnostic Information
Breast microcalcifications are small calcium deposits that are often detected on mammography and digital breast tomosynthesis. Clinicians use their morphology and distribution to assess suspicious breast... Read moreHealth IT
view channel
Clinical Decision Support Tool Automates CKD Risk Assessment in Primary Care
Chronic kidney disease (CKD) requires timely diagnosis, risk assessment, and coordinated treatment in primary care. Delayed recognition can affect decisions about testing, blood pressure control, cardiovascular... Read more
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Point of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Business
view channel
Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal
Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Stryker Enters Soft-Tissue Robotics Through Strategic Alliance With CMR Surgical
Stryker (Portage, MI, USA) and CMR Surgical (Cambridge, UK) have announced a strategic alliance centered on the Versius Surgical Robotic portfolio. The agreement includes an approximately USD 400 million... Read more
Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma
Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more